Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 26 Nov 2024 for REGIS CORP. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Matthew Doctor: trading record in brief
Matthew Doctor, listed as senior executive, appears in our data through filings on Regis Corp shares, published by SEC (Form 4). The record holds 9 filings, for trades running from 5 November 2021 to 22 November 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 26 November 2024, the filings show a share grant in Regis Corp. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Matthew Doctor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
16,500 shares0Common StockSEC:0001415889-24-027765:0
547 shares@ US$23.3712.8% of flowCommon StockSEC:0001415889-24-027260:0
339 shares@ US$23.378.0% of flowCommon StockSEC:0001415889-24-026379:0
211 shares@ US$12.352.6% of flowCommon StockSEC:0000716643-24-000010:0
3,648 shares@ US$0.532.0% of flowCommon StockSEC:0000716643-23-000048:0
2,837 shares@ US$1.263.9% of flowCommon StockSEC:0000716643-22-000090:0
4,343 shares@ US$1.6510.0% of flowCommon StockSEC:0000716643-22-000020:0
46,344 shares0Common StockSEC:0001179110-21-010175:0
12,234 shares@ US$2.7646.9% of flowCommon StockSEC:0000716643-21-000084:0
9 of 9 declarations
